Evidence map›Paper›PMID 31064333›Full record

ArticleBMC nephrology2019

Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report.

Stéphane Bally, Jacques Fourcade, Véronique Frémeaux-Bacchi

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Stéphane BallyService de Néphrologie Dialyse, Centre Hospitalier Métropole Savoie, Place Lucien Biset, BP 31125, 73 011, Chambery, Cedex, France. stephane.bally@ch-metropole-savoie.fr.ORCID 0000-0002-3963-1091
Jacques FourcadeService de Néphrologie Dialyse, Centre Hospitalier Métropole Savoie, Place Lucien Biset, BP 31125, 73 011, Chambery, Cedex, France.
Véronique Frémeaux-BacchiService d'Immunologie Biologique, Hôpital Européen Georges Pompidou (AP-HP), 20 rue Leblanc, 75 908, Paris, Cedex 15, France.
Centre Hospitalier Métropole Savoie · FRAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHaemolytic uraemic syndrome (HUS) is a thrombotic microangiopathy (TMA) characterized by predominant renal involvement. Several types of HUS can be distinguished: the most frequent « typical » HUS, due to shiga toxin producing Escherichia coli (STEC), "atypical" HUS due to complement alternative pathway dysregulation and "secondary" HUS associated with various diseases/conditions, the classification of which is still subject to debate. CASE PRESENTATION: We report a case of HUS following E.coli prostatitis and bacteraemia in an adult male. He presented with severe renal and neurological involvement. Initially considered as a "typical" HUS, the condition was treated by antibiotics. No other specific treatment for HUS was administered. The outcome was favorable. We eventually identified a non shiga toxin producing E.coli. Genetic testing of the complement alternative pathway revealed a rare - potentially pathogenic - variant of factor H. This constitutes a possible factor of susceptibility for atypical HUS, suggesting that E.coli infection may be the trigger.

conclusionThis case raises the question of complement exploration for HUS associated with infections, in order to classify such cases of HUS in accordance with their underlying pathophysiological mechanisms.

Indexed as

Escherichia coliAcute Kidney InjuryAtypical Hemolytic Uremic SyndromeBacteremiaBiopsyComplement Factor HConfusionEscherichia coli InfectionsHallucinationsHemorrhoidsHumansKidneyMaleMiddle AgedPostoperative ComplicationsRenal DialysisComplement Factor HComplement variantEscherichia coliHemolytic uremic syndromeInfection

Identifiers

PMID31064333
PMCPMC6505115
OpenAlexW2947657380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.